中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 3
Mar.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(3): 596-600

Clinical effect of laparoscopic splenectomy and pericardial devascularization in portal hypertension patients with Child-Pugh A/B liver function

DOI: 10.3969/j.issn.1001-5256.2021.03.018

  • Second Department of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun 130000, China

  • Received Date: 2020-09-06
  • Accepted Date: 2020-09-22
  • Published Date: 2021-03-20
    Abstract
  •   Objective  To investigate the clinical effect of laparoscopic splenectomy and pericardial devascularization (LSPD) in patients with portal hypertension and the long-term effect of LSPD.  Methods  A total of 40 portal hypertension patients with Child-Pugh A/B liver function who received LSPD in The First Hospital of Jilin University from August to December 2017 were enrolled as surgical group, and 44 portal hypertension patients with Child-Pugh A/B liver function who received conservative treatment during the same period of time was enrolled as internal medicine group. The patients were followed up to June 30, 2019, and liver function parameters, upper gastrointestinal bleeding, and portal vein thrombosis were recorded for all patients at each time point. The t-test was used for comparison of normally distributed continuous data between two groups; an analysis of variance was used for comparison between multiple groups, and the Bonferroni test was used for further comparison between two groups. The Kruskal-Wallis H test was used for comparison of continuous data with skewed distribution; between multiple groups, and the Mann-Whitney U test was used for further comparison between two groups. The chi-square test was used for comparison of categorical data between groups.  Results  At 6, 12, and 24 months after discharge, compared with the internal medicine group, the surgical group had a significantly higher level of cholinesterase (t=3.527, 3.849, and 5.555, all P < 0.05) and a significantly lower Child-Pugh score (t=2.498, 2.138, and 2.081, all P < 0.05). Compared with the internal medicine group at 12 and 24 months after discharge, the surgical group had a significantly higher level of albumin (t=3.120 and 2.587, both P < 0.05) and a significantly lower incidence rate of upper gastrointestinal bleeding (χ2=4.947 and 5.155, both P < 0.05). At 24 months after discharge, the surgical group had a significantly lower number of patients who had a significant increase in alpha-fetoprotein level than the internal medicine group (χ2=4.648, P=0.031). At 12 months after discharge, the surgical group had a significantly higher incidence rate of portal vein thrombosis than the internal medicine group (χ2=4.395, P=0.036). The surgical group had significant improvements in albumin (F=2.959, P=0.013), cholinesterase (F=11.022, P < 0.001), prothrombin time (H=94.100, P < 0.001), and Child-Pugh score (F=3.742, P=0.003) from admission to 12 and 24 months after surgery.  Conclusion  In portal hypertension patients with Child-Pugh A/B liver function, LSPD can improve liver function and reduce the incidence rate of upper gastrointestinal bleeding, and the high incidence rate of portal vein thrombosis can be effectively reduced by oral aspirin and rivaroxaban.

     

    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    HERRERA JL. Portal hypertension[J]. Clin Liver Dis, 2014, 18(2): xiii-xiv. DOI: 10.1016/j.cld.2014.02.001
    [2]
    BALDUCCI G, STERPETTI AV, VENTURA M. A short history of portal hypertension and of its management[J]. J Gastroenterol Hepatol, 2016, 31(3): 541-545. DOI: 10.1111/jgh.13200
    [3]
    ZHAO H, ZHAO R, HU J, et al. Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: Prevalence, characteristics, and impact on prognosis[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(3): 263-269. DOI: 10.1080/17474124.2019.1567329
    [4]
    HONG DF. Concept and technical innovation of laparoscopic splenectomy combined with peripheral cardia vascular interruption[J/CD]. Chin J Laparoscopic Surgery (Electronic Edition), 2018, 11(2): 68-71. (in Chinese)

    洪德飞. 腹腔镜脾切除联合贲门周围血管离断术理念与技术创新[J/CD]. 中华腔镜外科杂志(电子版), 2018, 11(2): 68-71.
    [5]
    ZHANG HW, WANG ML, ZHANG Z, et al. The impact of splenectomy and devascularization on liver function and liver fibrosis in patients with non-cirrhotic portal hypertension[J]. Chin J Hepatobiliary Surg, 2019, 25(7): 501-504. (in Chinese) http://d.wanfangdata.com.cn/periodical/sdyy202021015

    张宏伟, 王孟龙, 张振, 等. 脾切除联合贲门周围血管离断术对非硬化性门静脉高压患者肝功能及肝纤维化的影响[J]. 中华肝胆外科杂志, 2019, 25(7): 501-504 http://d.wanfangdata.com.cn/periodical/sdyy202021015
    [6]
    ZHANG Y, WEN TF, CHEN ZY, et al. Liver functions after periesophagogastric devascularization[J]. Chin J Gen Surg, 2009, 24(6): 470-472. (in Chinese) DOI: 10.3760/cma.j.issn.1007-631X.2009.06.014

    张宇, 文天夫, 陈哲宇, 等. 脾切除贲门周围血管离断术后肝脏血流动力学和储备功能的变化[J]. 中华普通外科杂志, 2009, 24(6): 470-472. DOI: 10.3760/cma.j.issn.1007-631X.2009.06.014
    [7]
    HUA R, WU ZY, SUN YW, et al. A study on the relationship between post-devascularization portal pressure and rebleeding in portal hypertensive patients[J]. Chin J Gen Surg, 2007, 22(3): 194-196. (in Chinese) DOI: 10.3760/j.issn:1007-631X.2007.03.010

    花荣, 吴志勇, 孙勇伟, 等. 断流术中门静脉压力变化及术后再出血的临床研究[J]. 中华普通外科杂志, 2007, 22(3): 194-196. DOI: 10.3760/j.issn:1007-631X.2007.03.010
    [8]
    JIANG FD, TIAN MG, YANG Y, et al. Changing rules of free portal pressure and influencing factors after splenectomy combined with pericardial devascularization[J]. Chin J Dig Surg, 2019, 18(4): 375-379. (in Chinese) DOI: 10.3760/cma.j.issn.1673-9752.2019.04.013

    蒋福东, 田明国, 杨勇, 等. 脾切除联合贲门周围血管离断术后自由门静脉压力变化规律及其影响因素分析[J]. 中华消化外科杂志, 2019, 18(4): 375-379. DOI: 10.3760/cma.j.issn.1673-9752.2019.04.013
    [9]
    ZHANG CY, LIU ZJ. Surgical treatment of cirrhotic portal hypertension: Current status and research advances[J]. J Clin Hepatol, 2020, 36(2): 417-420. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.02.040

    张春雨, 刘作金. 肝硬化门静脉高压外科治疗的现状及进展[J]. 临床肝胆病杂志, 2020, 36(2): 417-420. DOI: 10.3969/j.issn.1001-5256.2020.02.040
    [10]
    JIANG GQ, BAI DS, QIAN JJ, et al. Clinical efficacy of laparoscopic splenectomy combined with pericardial devascularization in the treatment of cirrhotic portal hypertension: A report of 445 cases[J]. Chin J Dig Surg, 2019, 18(12): 1136-1141. (in Chinese) DOI: 10.3760/cma.j.issn.1673-9752.2019.12.009

    蒋国庆, 柏斗胜, 钱建军, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症临床疗效分析(附425例报告)[J]. 中华消化外科杂志, 2019, 18(12): 1136-1141. DOI: 10.3760/cma.j.issn.1673-9752.2019.12.009
    [11]
    XU DW, SUN M, WU M, et al. Totally laparoscopic splenectomy plus pericardial devascularization in treatment of portal hypertension: Importance of surgical teamwork and technical hints[J]. Chin J Hepatobiliary Surg, 2019, 25(8): 611-615. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201405021.htm

    许丁伟, 孙敏, 吴敏, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗门静脉高压症的团队协作与技巧[J]. 中华肝胆外科杂志, 2019, 25(8): 611-615. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201405021.htm
    [12]
    BAI DS, ZHOU BH, QIAN JJ, et al. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: A 2-year prospective study[J]. Surg Endosc, 2020, 34(11): 5074-5082. DOI: 10.1007/s00464-019-07307-7
    [13]
    KOK B, ABRALDES JG. Child-Pugh classification: Time to abandon?[J]. Semin Liver Dis, 2019, 39(1): 96-103. DOI: 10.1055/s-0038-1676805
    [14]
    CHRISTENSEN E, SCHLICHTING P, FAUERHOLDT L, et al. Changes of laboratory variables with time in cirrhosis: Prognostic and therapeutic significance[J]. Hepatology, 1985, 5(5): 843-853. DOI: 10.1002/hep.1840050523
    [15]
    PAK JM, LEE SS. Glucagon in portal hypertension[J]. J Hepatol, 1994, 20(6): 825-832. DOI: 10.1016/S0168-8278(05)80156-4
    [16]
    LANGER DA, SHAH VH. Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis[J]. J Hepatol, 2006, 44(1): 209-216. DOI: 10.1016/j.jhep.2005.10.004
    [17]
    HSIN IF, HUANG HC, CHANG CC, et al. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes[J]. Clin Sci (Lond), 2018, 132(22): 2391-2405. DOI: 10.1042/CS20180557
    [18]
    MCKENZIE CV, COLONNE CK, YEO JH, et al. Splenomegaly: Pathophysiological bases and therapeutic options[J]. Int J Biochem Cell Biol, 2018, 94: 40-43. DOI: 10.1016/j.biocel.2017.11.011
    [19]
    RIVA MA, FERRAINA F, PALEARI A, et al. From sadness to stiffness: The spleen's progress[J]. Intern Emerg Med, 2019, 14(5): 739-743. DOI: 10.1007/s11739-019-02115-2
    [20]
    LEWIS SM, WILLIAMS A, EISENBARTH SC. Structure and function of the immune system in the spleen[J]. Sci Immunol, 2019, 4(33): eaau6085. DOI: 10.1126/sciimmunol.aau6085
    [21]
    ZHAO YP, JIANG HC, YANG LY, et al. General surgery[M]. 2nd ed. Beijing: People's Medical Publishing House, 2014. (in Chinese)

    赵玉沛, 姜洪池, 杨连粤, 等. 普通外科学[M]. 2版. 北京: 人民卫生出版社, 2014.
    [22]
    UEDA S, YAMANOI A, HISHIKAWA Y, et al. Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats[J]. Lab Invest, 2003, 83(11): 1595-1603. DOI: 10.1097/01.LAB.0000095686.10639.C8
    [23]
    LESURTEL M, GRAF R, ALEIL B, et al. Platelet-derived serotonin mediates liver regeneration[J]. Science, 2006, 312(5770): 104-107. DOI: 10.1126/science.1123842
    [24]
    CHEN XP, YANG LY, QIU GX, et al. Surgery(Volume 2)[M]. 2nd ed. Beijing: People's Medical Publishing House, 2010. (in Chinese)

    陈孝平, 杨连粤, 邱贵兴, 等. 外科学(下册)[M]. 2版. 北京: 人民卫生出版社, 2010.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (474) PDF downloads(37) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return